Gastrectomy clinical trials

Explore recruiting gastrectomy clinical trials.

Recruiting gastrectomy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastrectomy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The Pancreatic Enzymes after Gastrectomy Trial

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PERISCOPE-2

Sweden, Finland, Denmark, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

TremelImumab aNd durvalumab combination For the non-operatIve management (NOM) of Microsatellite InstabiliTY (MSI)-high resectable gastric or gastroesophageal junction cancer: The multicentre, single-arm, multi-cohort, Phase II INFINITY study.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, multicenter, prospective, single-arm, exploratory study to assess role of pancreatic enzyme replacement therapy (PERT) (Creon® 25,000) in patients with Pancreatic Exocrine Insufficiency (PEI) after total gastrectomy.

Portugal, Poland, Spain

Therapeutic use (Phase IV) EU CTIS Study details

Octreotide treatment to improve nutritional recovery after surgery for patients with esophageal or gastric cancer, a prospective randomized open label phase II study - OTIS

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

GASTRICHIP TRIAL. D2 resection and HIPEC (Hyperthermic IntraPeritoneal Chemoperfusion) in locally advanced gastric carcinoma. A randomized and multicentric phase III study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Gastrectomy trials by city

Gastrectomy in Toronto Gastrectomy in Vancouver Gastrectomy in Montreal Gastrectomy in Calgary Gastrectomy in Edmonton Gastrectomy in Ottawa Gastrectomy in Winnipeg Gastrectomy in Quebec City Gastrectomy in Hamilton Gastrectomy in Kitchener Gastrectomy in London Gastrectomy in Halifax Gastrectomy in New York Gastrectomy in Los Angeles Gastrectomy in Chicago Gastrectomy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease